Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | NASDAQ | Biotechnology | $5.49B | $61.77 | 2.98% | $53.57M | 257.38x | 2.70 | United States | ||
| SLNO | SOLENO THERAPEUTICS INC | NASDAQ | Biotechnology | $2.76B | $53.01 | 0.00% | $107.57M | 28.65x | 0.23 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $6.34B | $59.06 | 1.44% | -$6.87M | 128.39x | 0.28 | United States | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $39.85B | $298.48 | 1.42% | $924.47M | 68.46x | 3.77 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.18B | $68.98 | 0.36% | $623.82M | 23.30x | 11.17 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $8.90B | $302.05 | 2.98% | $213.96M | 38.97x | 0.09 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $1.98B | $8.56 | -0.81% | $221.54M | 12.41x | 0.70 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.81B | $35.40 | 2.64% | $40.42M | 82.33x | 0.36 | United States | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | NASDAQ | Biotechnology | $1.08B | $6.23 | 5.24% | $53.43M | 89.00x | 29.13 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $30.55B | $53.06 | 1.24% | $1.16B | 27.78x | 0.99 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $9.70B | $50.20 | 0.78% | $482.49M | 35.86x | 0.38 | United States | ||
| OMER | OMEROS CORP | NASDAQ | Biotechnology | $896.01M | $12.38 | 3.43% | $90.43M | 9.52x | -5.52 | United States | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $605.34M | $10.24 | 0.39% | $144.61M | 5.00x | 0.35 | United States | ||
| ASND | ASCENDIS PHARMA A | NASDAQ | Biotechnology | $14.99B | $241.34 | 1.41% | $93.26M | 25.58x | 3.11 | Denmark | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $15.00B | $239.01 | 0.66% | $675.03M | 508.53x | 1.62 | Ireland | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $4.18B | $54.28 | 1.76% | $111.49M | 55.39x | 0.36 | Bermuda | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $4.36B | $217.75 | 4.80% | $225.55M | 27.56x | 0.54 | United States | ||
| SPRO | SPERO THERAPEUTICS INC | NASDAQ | Biotechnology | $152.28M | $2.63 | 1.54% | $15.50M | 9.74x | 0.12 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.82B | $31.38 | 3.09% | $236.96M | 12.40x | 0.40 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $7.31B | $46.70 | 2.71% | $255.98M | 65.77x | 0.22 | United States | ||
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $6.09B | $39.76 | 0.84% | $150.00M | 12.35x | 1.62 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $12.54B | $49.90 | 2.53% | $1.06B | 15.99x | 0.34 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $23.94B | $563.93 | -0.51% | $1.71B | 19.26x | 0.14 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $298.67M | $3.75 | 2.18% | $21.24M | 15.63x | 0.39 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.82B | $31.25 | 0.13% | $334.94M | 17.27x | 0.13 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $109.25B | $430.44 | -0.89% | $5.39B | 25.31x | 0.37 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $3.61B | $45.19 | 8.40% | $115.05M | 40.71x | 0.07 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $564.50M | $3.79 | 4.12% | $54.47M | 18.05x | 0.27 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $161.95M | $2.01 | 5.79% | $22.33M | 10.58x | 0.52 | Israel | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $68.12B | $649.76 | 3.09% | $5.74B | 15.27x | 0.30 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $19.39B | $97.08 | 1.55% | $1.87B | 13.32x | 0.31 | United States | ||
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $1.81B | $17.12 | 2.88% | $82.73M | 28.53x | 1.11 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.